- Home
- VXRT vs PRE Comparison
VXRT vs PRE Comparison
Compare VXRT & PRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VXRT
- PRE
- Stock Information
- Founded
- VXRT N/A
- PRE 2014
- Country
- VXRT United States
- PRE Hong Kong
- Employees
- VXRT N/A
- PRE N/A
- Industry
- VXRT Biotechnology: Biological Products (No Diagnostic Substances)
- PRE Biotechnology: Laboratory Analytical Instruments
- Sector
- VXRT Health Care
- PRE Industrials
- Exchange
- VXRT Nasdaq
- PRE Nasdaq
- Market Cap
- VXRT 119.0M
- PRE 105.4M
- IPO Year
- VXRT N/A
- PRE N/A
- Fundamental
- Price
- VXRT $0.45
- PRE $9.20
- Analyst Decision
- VXRT Strong Buy
- PRE Buy
- Analyst Count
- VXRT 2
- PRE 1
- Target Price
- VXRT $3.00
- PRE $9.00
- AVG Volume (30 Days)
- VXRT 1.8M
- PRE 37.6K
- Earning Date
- VXRT 05-13-2025
- PRE 06-17-2025
- Dividend Yield
- VXRT N/A
- PRE N/A
- EPS Growth
- VXRT N/A
- PRE N/A
- EPS
- VXRT N/A
- PRE N/A
- Revenue
- VXRT $47,395,000.00
- PRE $30,621,000.00
- Revenue This Year
- VXRT N/A
- PRE $148.70
- Revenue Next Year
- VXRT N/A
- PRE $82.89
- P/E Ratio
- VXRT N/A
- PRE N/A
- Revenue Growth
- VXRT 433.43
- PRE 40.83
- 52 Week Low
- VXRT $0.29
- PRE $3.10
- 52 Week High
- VXRT $1.07
- PRE $11.99
- Technical
- Relative Strength Index (RSI)
- VXRT 51.74
- PRE 67.68
- Support Level
- VXRT $0.42
- PRE $5.08
- Resistance Level
- VXRT $0.48
- PRE $11.99
- Average True Range (ATR)
- VXRT 0.04
- PRE 0.88
- MACD
- VXRT -0.00
- PRE 0.18
- Stochastic Oscillator
- VXRT 47.06
- PRE 59.51
About VXRT Vaxart Inc
Vaxart Inc is a clinical-stage biotechnology company. It focuses on the development of oral recombinant vaccines to protect against a wide range of infectious diseases. The products under its tablet pipeline consist of the treatment of Coronavirus, Norovirus, Seasonal Influenza, RSV(respiratory syncytial virus), and HPV(Human papillomavirus) Therapeutic. It operates in a single segment, which is the discovery and development of oral recombinant protein vaccines. Geographically all the business activity functions through the region of the United States.
About PRE Prenetics Global Limited
Prenetics Global Ltd is a health sciences company dedicated to consumer and clinical health. Its consumer initiative is led by IM8, a new health and wellness brand, and Europa, a U.S. sports distribution company. The clinical division is led by Insighta, focused on multi-cancer early detection technologies. This is followed by ACT Genomics, which has achieved FDA clearance for genomic profiling of solid tumors, and CircleDNA, which uses NGS to offer DNA tests. Each Prenetics unit impacts health by 'enhancing life through science'.